These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27315220)

  • 1. Glucagon-like peptide-1 drives energy metabolism on the synaptic highway.
    Liu J; Pang ZP
    FEBS J; 2016 Dec; 283(24):4413-4423. PubMed ID: 27315220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Val⁸-GLP-1 remodels synaptic activity and intracellular calcium homeostasis impaired by amyloid β peptide in rats.
    Wang XH; Yang W; Hölscher C; Wang ZJ; Cai HY; Li QS; Qi JS
    J Neurosci Res; 2013 Apr; 91(4):568-77. PubMed ID: 23335292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 modulates synaptic transmission to identified pancreas-projecting vagal motoneurons.
    Wan S; Browning KN; Travagli RA
    Peptides; 2007 Nov; 28(11):2184-91. PubMed ID: 17889966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the glucagon-like-peptide-1 receptor in the control of energy balance.
    Hayes MR; De Jonghe BC; Kanoski SE
    Physiol Behav; 2010 Jul; 100(5):503-10. PubMed ID: 20226203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incretin hormone glucagon-like peptide 1 increases mitral cell excitability by decreasing conductance of a voltage-dependent potassium channel.
    Thiebaud N; Llewellyn-Smith IJ; Gribble F; Reimann F; Trapp S; Fadool DA
    J Physiol; 2016 May; 594(10):2607-28. PubMed ID: 26931093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 inhibits voltage-gated potassium currents in mouse nodose ganglion neurons.
    Gaisano GG; Park SJ; Daly DM; Beyak MJ
    Neurogastroenterol Motil; 2010 Apr; 22(4):470-9, e111. PubMed ID: 20003076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLP-1 and exendin-4 transiently enhance GABAA receptor-mediated synaptic and tonic currents in rat hippocampal CA3 pyramidal neurons.
    Korol SV; Jin Z; Babateen O; Birnir B
    Diabetes; 2015 Jan; 64(1):79-89. PubMed ID: 25114295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects.
    Hayes MR
    Physiol Behav; 2012 Jun; 106(3):413-6. PubMed ID: 22366059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 receptor in the brain: role in neuroendocrine control of energy metabolism and treatment target for obesity.
    Lockie SH
    J Neuroendocrinol; 2013 Jul; 25(7):597-604. PubMed ID: 23590331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Glucagon-Like Peptide-1 in Energy Homeostasis.
    Salehi M; Purnell JQ
    Metab Syndr Relat Disord; 2019 May; 17(4):183-191. PubMed ID: 30720393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system.
    Osaka T; Endo M; Yamakawa M; Inoue S
    Peptides; 2005 Sep; 26(9):1623-31. PubMed ID: 16112402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.
    Wang XH; Li L; Hölscher C; Pan YF; Chen XR; Qi JS
    Neuroscience; 2010 Nov; 170(4):1239-48. PubMed ID: 20727946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors.
    Amato A; Cinci L; Rotondo A; Serio R; Faussone-Pellegrini MS; Vannucchi MG; Mulè F
    Neurogastroenterol Motil; 2010 Jun; 22(6):664-e203. PubMed ID: 20158614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a gut-brain axis used by glucagon-like peptide-1 to elicit hyperglycaemia in fish.
    Polakof S; Míguez JM; Soengas JL
    J Neuroendocrinol; 2011 Jun; 23(6):508-18. PubMed ID: 21564347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.
    Hou Y; Ernst SA; Heidenreich K; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G26-33. PubMed ID: 26542397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
    Baggio LL; Huang Q; Cao X; Drucker DJ
    Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease.
    McClean PL; Gault VA; Harriott P; Hölscher C
    Eur J Pharmacol; 2010 Mar; 630(1-3):158-62. PubMed ID: 20035739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for glucagon-like peptide-1 receptor signaling to activate ATP-sensitive potassium channels in pancreatic beta cells.
    Kwon HJ; Park HS; Park SH; Park JH; Shin SK; Song SE; Hwang M; Cho HC; Song DK
    Biochem Biophys Res Commun; 2016 Jan; 469(2):216-21. PubMed ID: 26655814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anorexigenic effects of GLP-1 and its analogues.
    Gallwitz B
    Handb Exp Pharmacol; 2012; (209):185-207. PubMed ID: 22249815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease.
    Sandoval DA; D'Alessio DA
    Physiol Rev; 2015 Apr; 95(2):513-48. PubMed ID: 25834231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.